Publication | Closed Access

Urolithin A suppresses RANKL-induced osteoclastogenesis and postmenopausal osteoporosis by, suppresses inflammation and downstream NF-κB activated pyroptosis pathways

InflammationBone DiseaseUrologyDownstream Nf-κbMedicineRenal InflammationOsteoporosisBone HomeostasisPyroptosis PathwaysMetabolic SignalingPostmenopausal OsteoporosisCell BiologyCell SignalingBone Metabolism